What is Millar?
Founded in 1969, Millar has established itself as a cornerstone in the research, development, and manufacture of advanced pressure sensor technology. The company's product portfolio is extensive, featuring pressure transducer catheters, sophisticated pressure-volume loop systems, and wireless implantable animal telemetry. These tools are essential for biopotential and tissue oxygen monitoring, serving as the gold standard for researchers and clinicians who require high-fidelity data. With its headquarters in Houston, Texas, Millar operates at the intersection of engineering excellence and medical necessity, providing the hardware infrastructure required for complex cardiovascular and physiological studies.
How much funding has Millar raised?
Millar has raised a total of $2.4M across 2 funding rounds:
Debt
$1M
Debt
$1.4M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.4M led by PPP
Key Investors in Millar
PPP
Public-Private Partnership
What's next for Millar?
With the recent capital injection, Millar is positioned to accelerate its R&D initiatives and expand its footprint in the medical device landscape. The company's strategic focus will likely center on enhancing its wireless telemetry capabilities and refining its pressure-volume loop systems to meet the evolving demands of modern clinical trials. As the firm navigates this phase of enterprise-level growth, the emphasis remains on maintaining its reputation for precision while scaling manufacturing operations to support a broader international client base. This financial backing provides the necessary runway to explore next-generation sensor integration and potential market diversification within the broader life sciences sector.
See full Millar company page
